DaltonTx appoints Melissa Landon as Chief Commercial Officer to drive commercial growth and strategic partnerships

  • Dr Landon brings 20+ years of experience in the application of AI/ ML to drug discovery
  • She joins DaltonTx to drive adoption of DaltonTx platform across pharma, biotech and CROs
London, UK – 12 November 2026 – DaltonTx, the decision engine for drug discovery, today announced the appointment of Melissa Landon, Ph.D., as Chief Commercial Officer to lead the company’s commercial strategy.
© Optimum Strategic Communications.